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SUMMARY. Docking studies of few substituted 5-benzyl-2, 4-thiazolidinedione moiety, which acts as per-
oxisome proliferator-activated receptor γ agonist was performed by using Glide v4.5. The docking studies
reveal hydrogen bond formation to Thr241 with Gscore -7.22 and energy -62.2 kcal/mole. We found hy-
drogen bond formation of most of compounds with good Gscore and low energy as compared to the most
active rosiglitazone.
